Tan Xiangduan, Wang Panfeng, Nian Siyun, Wang Guoping
Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry.
Chem Pharm Bull (Tokyo). 2014;62(1):112-7. doi: 10.1248/cpb.c13-00623. Epub 2013 Oct 25.
In this study, a series of amide derivatives were synthesized and evaluated for their S-adenosyl-L-homocysteine hydrolase (SAHase) inhibitory activities. The results demonstrated that most of compounds displayed potent SAHase inhibitory activities. Interestingly, compounds 11 and 14 exhibited more potent inhibitory effects than the aristeromycin, one of the most potent SAHase inhibitors known so far. Compounds 12, 13, 15 and 17 exhibited a moderate effect (IC50<10.0 µM). The structure-activity relationship found that compounds with substituted indazole-5-yl group at Ar position and ethylamino group at the side chain showed better SAHase inhibitory activities.
在本研究中,合成了一系列酰胺衍生物,并对其S-腺苷-L-高半胱氨酸水解酶(SAHase)抑制活性进行了评估。结果表明,大多数化合物表现出较强的SAHase抑制活性。有趣的是,化合物11和14表现出比阿瑞吡坦更强的抑制作用,阿瑞吡坦是迄今为止已知的最有效的SAHase抑制剂之一。化合物12、13、15和17表现出中等效果(IC50<10.0µM)。构效关系发现,在Ar位带有取代吲唑-5-基且侧链带有乙氨基的化合物表现出更好的SAHase抑制活性。